Maravai LifeSciences Holdings, Inc. financial statements, including revenue, expenses, and profit
The total revenue of MRVI for the last quarter is 56.41 M USD, and it's 13.49% lower compared to the previous quarter. The net income of Q4 24 is -26.14 M USD.